Zuntová A, Sumerauer D, Teslík L, Kabícková E, Koutecký J
Ustav pathologie a molekulární medicíny 2, LF UK a FN Motol, Praha.
Cesk Patol. 2004 Jul;40(3):92-101.
Mixed germ cell tumours of the ovary are rare malignant neoplasms containing combinations of two or more types of germ cell elements. The aim of the study was to review biopsy examinations, medical records, treatment strategy, follow-up and outcome of all girls treated for mixed germ cell tumour of the ovary at the Department of Pediatric Oncology, University Hospital Motol during the period 1979-2002. Archival slides of all tumours were reviewed and tumours were classified according to the WHO system. The clinical data on surgical treatment, chemotherapy and radiotherapy used and follow-up information were obtained in all girls. The staging was reviewed retrospectively on the basis of surgical and pathological findings and results of imaging investigations, and it was outlined according to the most recent FIGO criteria and TNM classification. Sixteen girls with mixed germ cell tumour of the ovary, age range 3 years 11 months to 17 years 8 months (median 12 years) were treated. All girls presented with unilateral tumour of the ovary and all underwent surgery as an initial treatment. The most common presenting symptom was abdominal pain, occurring in ten patients. The original diagnosis of mixed histology was confirmed in all cases; in five cases the tumour contained three histologic components, in eleven cases the tumour consisted of two germ cell types. All tumours contained elements of yolk sac tumour, followed by immature teratoma, embryonal carcinoma, dysgerminoma and mature teratoma. At the time of diagnosis three patients had stage I disease, four patients stage II, seven stage III and two stage IV disease. All patients were treated with chemotherapy after surgery, predominantly with platinum-based regimens (PVB, BEP). Three patients treated initially with MAC (metothrexate, dactinomycin, cyclophosphamide) were diagnosed in the early eighties. In seven girls with advanced disease treated in the early years, radiotherapy was administered to the pelvis or whole abdomen. Overall survival and event-free survival were 80% and 81.3% respectively (median follow-up time 7.6 years). Three patients have died from the disease, two progressed on treatment (MAC), one girl relapsed three months after finishing therapy, no further therapy was administered. One girl underwent resection of tumour of her remaining ovary 24 months after original diagnosis. Histology showed mixed serous and mucinous cystadenoma. The latest examinations revealed that all other patients were in good health. Microscopic examination should be extensive and careful to find out all types of malignant germ cell elements. Platinum based chemotherapy is effective in the management of children and adolescents with mixed germ cell tumors of the ovary. Chemosensitivity of these tumours allows most girls to have conservative surgery with possible preservation of reproductive function.
卵巢混合性生殖细胞肿瘤是罕见的恶性肿瘤,包含两种或更多种生殖细胞成分的组合。本研究的目的是回顾1979年至2002年期间在Motol大学医院儿科肿瘤科接受卵巢混合性生殖细胞肿瘤治疗的所有女孩的活检检查、病历、治疗策略、随访情况及预后。对所有肿瘤的存档切片进行了复查,并根据世界卫生组织系统对肿瘤进行分类。获取了所有女孩关于手术治疗、化疗和放疗使用情况以及随访信息的临床数据。根据手术和病理结果以及影像学检查结果对分期进行回顾性评估,并按照最新的国际妇产科联盟(FIGO)标准和TNM分类进行概述。16名患有卵巢混合性生殖细胞肿瘤的女孩接受了治疗,年龄范围为3岁11个月至17岁8个月(中位年龄12岁)。所有女孩均表现为单侧卵巢肿瘤,且均接受了手术作为初始治疗。最常见的症状是腹痛,10名患者出现此症状。所有病例均确诊为混合组织学;5例肿瘤包含三种组织学成分,11例肿瘤由两种生殖细胞类型组成。所有肿瘤均含有卵黄囊瘤成分,其次是未成熟畸胎瘤、胚胎癌、无性细胞瘤和成熟畸胎瘤。诊断时,3例患者为I期疾病,4例为II期,7例为III期,2例为IV期。所有患者术后均接受化疗,主要采用铂类方案(PVB、BEP)。最初用MAC(甲氨蝶呤、放线菌素D、环磷酰胺)治疗的3例患者于80年代初确诊。在早期接受治疗的7例晚期疾病女孩中,对盆腔或全腹进行了放疗。总生存率和无事件生存率分别为80%和81.3%(中位随访时间7.6年)。3例患者死于该疾病,2例在治疗过程中病情进展(MAC方案),1名女孩在完成治疗3个月后复发,未再给予进一步治疗。1名女孩在初次诊断24个月后对其剩余卵巢的肿瘤进行了切除。组织学显示为浆液性和黏液性混合性囊腺瘤。最新检查显示,所有其他患者健康状况良好。显微镜检查应广泛且仔细,以找出所有类型的恶性生殖细胞成分。铂类化疗对治疗患有卵巢混合性生殖细胞肿瘤的儿童和青少年有效。这些肿瘤的化疗敏感性使大多数女孩能够进行保留生育功能的保守手术。